**Basic purpose of the job:**

Manage the timely clinical development(CD) and Health Authority(HA) approval of NBI assets for target indications by providing appropriate and robust insights in [TA name] area, based on Japanese TA-specific and healthcare environment, in collaboration with Corporate&Japan (Early) Asset Team(s), (Early) Evidence Lead(s) and respective Evidence and Value Network

**Accountabilities:**

CD Strategy Planning:
- Evaluate and propose Japan (early)CD strategy to achieve asset Target Product Profile(TPP) and value proposition; Ensure CD strategy integrating Japan needs (including but not limited to local medical, competitive landscape and differentiation) in alignment with global asset strategy and agreed by Japan&Corp (early) Asset Team(s).
- Inform respective Evidence Network to highlight the local evidence gaps that are not addressed via Clinical Trials (CTs) for the relevant business function and their planning of Real World Evi...